Sio Capital Management, LLC Hedge Fund

Location: New York, NY

CIK: 0001482416 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 15, 2016

Total Value: $145M (100.0% shares, 0.0% debt)

Holdings (32)

— QUOTIENT LTD 11.8%
Value $17.09M Shares 2,185,669 Share Price $7.82 Est. Cost/Share $14.03 Unrealized @ Report Date —
AMGN AMGEN INC 10.5%
Value $15.23M Shares 91,300 Share Price $166.81 * Est. Cost/Share $110.79 Unrealized @ Report Date +15.3%
PHG KONINKLIJKE PHILIPS N V 9.4%
Value $13.69M Shares 462,662 Share Price $29.59 Est. Cost/Share $28.32 Unrealized @ Report Date —
CAH CARDINAL HEALTH INC 7.2%
Value $10.41M Shares 133,937 Share Price $77.70 * Est. Cost/Share $60.99 Unrealized @ Report Date +0.8%
SNY SANOFI 5.9%
Value $8.531M Shares 223,380 Share Price $38.19 Est. Cost/Share $43.75 Unrealized @ Report Date —
— TABULA RASA HEALTHCARE INC 5.0%
Value $7.303M Shares 510,000 Share Price $14.32 Est. Cost/Share $14.32 Unrealized @ Report Date —
— ATHENAHEALTH INC 5.0%
Value $7.265M Shares 57,600 Share Price $126.13 Est. Cost/Share — Unrealized @ Report Date —
— MEDICINES CO 4.7%
Value $6.782M Shares 179,700 Share Price $37.74 Est. Cost/Share — Unrealized @ Report Date —
SRPT SAREPTA THERAPEUTICS INC 3.7%
Value $5.312M Shares 86,500 Share Price $61.41 Est. Cost/Share — Unrealized @ Report Date —
— HILL ROM HLDGS INC 2.6%
Value $3.799M Shares 61,299 Share Price $61.97 Est. Cost/Share $50.45 Unrealized @ Report Date —
— RIGEL PHARMACEUTICALS INC 2.6%
Value $3.746M Shares 1,020,719 Share Price $3.67 Est. Cost/Share $2.08 Unrealized @ Report Date —
— CHEMOCENTRYX INC 2.6%
Value $3.708M Shares 613,890 Share Price $6.04 Est. Cost/Share $4.49 Unrealized @ Report Date —
— CERNER CORP 2.6%
Value $3.705M Shares 60,000 Share Price $61.75 Est. Cost/Share — Unrealized @ Report Date —
PRGO PERRIGO CO PLC 2.5%
Value $3.597M Shares 38,953 Share Price $92.34 Est. Cost/Share $92.15 Unrealized @ Report Date 0.0%
MEDP MEDPACE HLDGS INC 2.4%
Value $3.465M Shares 116,053 Share Price $29.86 * Est. Cost/Share $29.20 Unrealized @ Report Date 0.0%
— ABBVIE INC 2.2%
Value $3.154M Shares 50,000 Share Price $63.08 Est. Cost/Share — Unrealized @ Report Date —
— ADVANCED ACCELERATOR APPLIC 2.0%
Value $2.877M Shares 75,557 Share Price $38.08 Est. Cost/Share $31.27 Unrealized @ Report Date —
— ANTHERA PHARMACEUTICALS INC 2.0%
Value $2.839M Shares 901,115 Share Price $3.15 Est. Cost/Share $4.68 Unrealized @ Report Date —
— ADAMIS PHARMACEUTICALS CORP 1.6%
Value $2.283M Shares 665,455 Share Price $3.43 Est. Cost/Share $5.96 Unrealized @ Report Date —
ASND ASCENDIS PHARMA A S 1.6%
Value $2.261M Shares 112,497 Share Price $20.10 Est. Cost/Share $17.38 Unrealized @ Report Date —
— NATUS MEDICAL INC 1.5%
Value $2.2M Shares 56,000 Share Price $39.29 Est. Cost/Share $39.29 Unrealized @ Report Date —
— ACETO CORP 1.5%
Value $2.199M Shares 115,781 Share Price $18.99 Est. Cost/Share $18.99 Unrealized @ Report Date —
— ACTINIUM PHARMACEUTICALS INC 1.5%
Value $2.16M Shares 1,600,000 Share Price $1.35 Est. Cost/Share $1.35 Unrealized @ Report Date —
UNH UNITEDHEALTH GROUP INC 1.5%
Value $2.107M Shares 15,049 Share Price $140.01 * Est. Cost/Share $120.51 Unrealized @ Report Date 0.0%
CHRS COHERUS BIOSCIENCES INC 1.3%
Value $1.956M Shares 73,053 Share Price $26.78 Est. Cost/Share $27.28 Unrealized @ Report Date 0.0%
— FORWARD PHARMA A/S 1.2%
Value $1.786M Shares 85,108 Share Price $20.99 Est. Cost/Share $17.92 Unrealized @ Report Date —
— ALMOST FAMILY INC 0.9%
Value $1.341M Shares 36,479 Share Price $36.76 Est. Cost/Share $41.31 Unrealized @ Report Date —
VKTX VIKING THERAPEUTICS INC 0.8%
Value $1.191M Shares 849,905 Share Price $1.40 * Est. Cost/Share $1.32 Unrealized @ Report Date +0.2%
— ADAMAS PHARMACEUTICALS INC 0.7%
Value $1.085M Shares 66,110 Share Price $16.41 Est. Cost/Share $16.27 Unrealized @ Report Date —
— AEGLEA BIOTHERAPEUTICS INC 0.7%
Value $989K Shares 154,332 Share Price $6.41 Est. Cost/Share $4.99 Unrealized @ Report Date —
— PFENEX INC 0.4%
Value $578K Shares 64,556 Share Price $8.95 Est. Cost/Share $9.77 Unrealized @ Report Date —
OASMY OASMIA PHARMACEUTICAL AB 0.3%
Value $365K Shares 122,100 Share Price $2.99 Est. Cost/Share $3.62 Unrealized @ Report Date —